The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Pfizer has had a rough year, underperforming both the broader market and its pharmaceutical peers. Shares are down 4.7% over ...

Three supercharged income stocks -- sporting an average yield of 8.63% -- are perfectly positioned to fatten investors' pocketbooks.

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

As the state faces a multimillion dollar measles outbreak in West Texas, the House Public Health Committee passes HB 1586 ...

Health Secretary Robert F. Kennedy Jr. on Thursday announced plans to require all new vaccines to be tested against placebos ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

4 July 2024 UK leg of global litigation over mRNA tech sees patents ruled valid and invalid | Justice Meade follows EPO in ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

Several current and former FDA employees who spoke to Inside Medicine on the condition of anonymity have come to see the ...